is retatrutide safe for type 1 diabetes Retatrutide—A Game Changer in Obesity Pharmacotherapy 🚨Breaking: Retatrutide's first Phase 3

Hui, H., Nourparvar, A., Zhao, X

Research indicates that approximately 32% of participants achieved a decrease in body mass of at least 25%

Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones Metabol (2016) 48(7):47683

Sep 2024 - Global pharmaceutical company Amneal Pharmaceuticals, Inc., and clinical-stage biopharmaceutical company Metsera, Inc., are accelerating next-generation medicines for obesity and metabolic diseases by joining forces with a portfolio of new weight loss medicines on efficient development and large-scale supply worldwide

Misaligned patient-payer expectations are the gaps between what patients believe should be covered and what payers can reasonably fund based on evidence, regulation, and cost

It is an investigational triple hormone receptor agonist